PPARGC1A and Headache: Our findings showed that the inhibitors of Sirt3 and Pgc-1α increased nociceptive responses, injured mitochondrial function and suppressed mitochondrial biogenesis (Figs. 5 and 6), indicating that Sirt3 and Pgc-1α may represent potential targets for therapeutic intervention of headache.